gyy-4137 and Osteoporosis

gyy-4137 has been researched along with Osteoporosis* in 1 studies

Other Studies

1 other study(ies) available for gyy-4137 and Osteoporosis

Article	Year
Experimental research into the potential therapeutic effect of GYY4137 on Ovariectomy-induced osteoporosis. Cellular & molecular biology letters, 2018, Volume: 23 Evidence has shown that endogenous H. The OVX osteoporosis model was established in female Sprague-Dawley rats by full bilateral ovariectomy. The rats were randomly divided into four groups, with the two experimental groups receiving an intraperitoneal injection of GYY4137 or sodium alendronate. The level of H. The OVX osteoporosis model was successfully established. GYY4137 was injected to increase the level of H. Through the slow release of H Topics: Animals; Biomechanical Phenomena; Bone and Bones; Bone Density; Calcium; Disease Models, Animal; Female; Hormones; Morpholines; Organothiophosphorus Compounds; Osteoporosis; Ovariectomy; Phosphorus; Rats, Sprague-Dawley	2018

Article

Year

Experimental research into the potential therapeutic effect of GYY4137 on Ovariectomy-induced osteoporosis.

Cellular & molecular biology letters, 2018, Volume: 23

Evidence has shown that endogenous H. The OVX osteoporosis model was established in female Sprague-Dawley rats by full bilateral ovariectomy. The rats were randomly divided into four groups, with the two experimental groups receiving an intraperitoneal injection of GYY4137 or sodium alendronate. The level of H. The OVX osteoporosis model was successfully established. GYY4137 was injected to increase the level of H. Through the slow release of H

Topics: Animals; Biomechanical Phenomena; Bone and Bones; Bone Density; Calcium; Disease Models, Animal; Female; Hormones; Morpholines; Organothiophosphorus Compounds; Osteoporosis; Ovariectomy; Phosphorus; Rats, Sprague-Dawley

2018